J. Parsonnet, G. Friedman, D. Vandersteen, Y. Chang, J. Vogelman et al., Infection and the Risk of Gastric Carcinoma, New England Journal of Medicine, vol.325, issue.16, pp.1127-1131, 1991.
DOI : 10.1056/NEJM199110173251603

M. Garcia, R. J. Garnier, M. Cremniter, J. Burucoa, and C. , Distribution of Spontaneous gyrA Mutations in 97 Fluoroquinolone-Resistant Helicobacter pylori Isolates Collected in France, Antimicrobial Agents and Chemotherapy, vol.56, issue.1, pp.550-551, 2012.
DOI : 10.1128/AAC.05243-11

A. Godoy, M. Ribeiro, Y. Benvengo, L. Vitiello, M. Mde et al., Analysis of antimicrobial susceptibility and virulence factors in Helicobacter pyloriclinical isolates, BMC Gastroenterology, vol.12, issue.1, p.20, 2003.
DOI : 10.1099/0022-1317-51-9-786

S. Nahar, A. Mukhopadhyay, R. Khan, M. Ahmad, S. Datta et al., Antimicrobial Susceptibility of Helicobacter pylori Strains Isolated in Bangladesh, Journal of Clinical Microbiology, vol.42, issue.10, pp.4856-4858, 2004.
DOI : 10.1128/JCM.42.10.4856-4858.2004

O. Aboderin, A. Abdu, B. Odetoyin, I. Okeke, O. Lawal et al., Antibiotic resistance of Helicobacter pylori from patients in Ile-Ife, South-west, Nigeria, Afr Health Sci, vol.7, pp.143-147, 2007.

A. Seck, M. Mbengue, A. Gassama-sow, L. Diouf, M. Ka et al., Antibiotic susceptibility of Helicobacter pylori isolates in Dakar, Senegal, The Journal of Infection in Developing Countries, vol.3, issue.02, pp.137-140, 2009.
DOI : 10.3855/jidc.512

URL : https://hal.archives-ouvertes.fr/pasteur-00584222

R. Ndip, M. Takang, A. Ojongokpoko, J. Luma, H. Malongue et al., Helicobacter pylori isolates recovered from gastric biopsies of patients with gastro-duodenal pathologies in Cameroon: current status of antibiogram, Tropical Medicine & International Health, vol.33, issue.Suppl. 1, pp.848-854, 2008.
DOI : 10.1111/j.1365-3156.2008.02062.x

A. Price, Classification of gastritis?yesterday, today and tomorrow, Verhandlungen der Deutschen Gesellschaft fur Pathologie, vol.83, pp.52-55, 1999.

R. Schlemper, R. Riddell, Y. Kato, F. Borchard, H. Cooper et al., The Vienna classification of gastrointestinal epithelial neoplasia, Gut, vol.47, issue.2, pp.251-255, 2000.
DOI : 10.1136/gut.47.2.251

B. Mansour, K. Burucoa, C. Zribi, M. Masmoudi, A. Karoui et al., Primary resistance to clarithromycin, metronidazole and amoxicillin of Helicobacter pylori isolated from Tunisian patients with peptic ulcers and gastritis: a prospective multicentre study, Annals of Clinical Microbiology and Antimicrobials, vol.9, issue.1, p.22, 2010.
DOI : 10.1186/1476-0711-9-22

E. Glocker, H. Stueger, and M. Kist, Quinolone Resistance in Helicobacter pylori Isolates in Germany, Antimicrobial Agents and Chemotherapy, vol.51, issue.1, pp.346-349, 2007.
DOI : 10.1128/AAC.00614-06

K. Hung, B. Sheu, W. Chang, H. Wu, C. Liu et al., at a University Hospital in Southern Taiwan, Helicobacter, vol.43, issue.1, pp.61-65, 2009.
DOI : 10.1111/j.1523-5378.2009.00655.x

J. Kim, J. Kim, N. Kim, H. Jung, and I. Song, Distribution of fluoroquinolone MICs in Helicobacter pylori strains from Korean patients, Journal of Antimicrobial Chemotherapy, vol.56, issue.5, pp.965-967, 2005.
DOI : 10.1093/jac/dki334

J. Tankovic, C. Lascols, Q. Sculo, J. Petit, and C. Soussy, Single and Double Mutations in gyrA but Not in gyrB Are Associated with Low- and High-Level Fluoroquinolone Resistance in Helicobacter pylori, Antimicrobial Agents and Chemotherapy, vol.47, issue.12, pp.3942-3944, 2003.
DOI : 10.1128/AAC.47.12.3942-3944.2003

V. Cattoir, J. Nectoux, C. Lascols, L. Deforges, J. Delchier et al., Update on fluoroquinolone resistance in Helicobacter pylori: new mutations leading to resistance and first description of a gyrA polymorphism associated with hypersusceptibility, International Journal of Antimicrobial Agents, vol.29, issue.4, pp.389-396, 2007.
DOI : 10.1016/j.ijantimicag.2006.11.007

A. Cuadrado-lavin, J. Salcines-caviedes, M. Carrascosa, P. Mellado, I. Monteagudo et al., Antimicrobial susceptibility of Helicobacter pylori to six antibiotics currently used in Spain, Journal of Antimicrobial Chemotherapy, vol.67, issue.1, pp.170-173, 2012.
DOI : 10.1093/jac/dkr410

L. Boyanova and I. Mitov, resistance to antibacterial agents, Expert Review of Anti-infective Therapy, vol.8, issue.1, pp.59-70, 2010.
DOI : 10.1586/eri.09.113

J. Sire, P. Nabeth, J. Perrier-gros-claude, I. Bahsoun, T. Siby et al., Antimicrobial resistance in outpatient Escherichia coli urinary isolates in Dakar, Senegal, J Infect Dev Ctries, vol.1, pp.263-268, 2007.
URL : https://hal.archives-ouvertes.fr/pasteur-00624409

D. Francesco, V. Giorgio, F. Hassan, C. Manes, G. Vannella et al., Worldwide Helicobacter pylori antibiotic resistance: a systematic review, J Gastrointestin Liver Dis, vol.19, pp.409-414, 2010.

M. Sherif, Z. Mohran, H. Fathy, D. Rockabrand, P. Rozmajzl et al., Universal High-Level Primary Metronidazole Resistance in Helicobacter pylori Isolated from Children in Egypt, Journal of Clinical Microbiology, vol.42, issue.10, pp.4832-4834, 2004.
DOI : 10.1128/JCM.42.10.4832-4834.2004

D. Asrat, E. Kassa, Y. Mengistu, I. Nilsson, and T. Wadstrom, Antimicrobial susceptibility pattern of Helicobacter pylori strains isolated from adult dyspeptic patients in Tikur Anbassa University Hospital, Ethiop Med J, vol.42, pp.79-85, 2004.

J. Gisbert, Rescue Therapy for Helicobacter pylori Infection 2012, Gastroenterol Res Pract, 2012.

J. Liou, C. Chen, M. Chen, C. Chang, Y. Fang et al., Sequential versus triple therapy for the first-line treatment of Helicobacter pylori: a multicentre, open-label, randomised trial, The Lancet, vol.381, issue.9862, 2012.
DOI : 10.1016/S0140-6736(12)61579-7